Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Gene Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Gene Therapymarket, defines the market attractiveness level of Cancer Gene Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Gene Therapy industry, describes the types of Cancer Gene Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Gene Therapy market and the development prospects and opportunities of Cancer Gene Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Gene Therapy market in Chapter 13.
By Player:
Merck
GlaxoSmithKline
Adaptimmune
OncoGenex Pharmaceuticals
Bluebird bio, Inc
Celgene
SynerGene Therapeutics
BioCancell
Shenzhen SiBiono GeneTech
Shanghai Sunway Biotech
By Type:
Ex-vivo
In-vivo
By End-User:
Biopharma Companies
Research Institutes
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Gene Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Gene Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Gene Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Gene Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Gene Therapy Market Analysis and Outlook to 2022
-
7.1 Global Cancer Gene Therapy Consumption (2017-2022)
-
7.2 United States Cancer Gene Therapy Consumption (2017-2022)
-
7.3 Europe Cancer Gene Therapy Consumption (2017-2022)
-
7.4 China Cancer Gene Therapy Consumption (2017-2022)
-
7.5 Japan Cancer Gene Therapy Consumption (2017-2022)
-
7.6 India Cancer Gene Therapy Consumption (2017-2022)
-
7.7 South Korea Cancer Gene Therapy Consumption (2017-2022)
8 Region and Country-wise Cancer Gene Therapy Market Analysis and Outlook to 2028
-
8.1 Global Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.2 United States Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.4 China Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.6 India Cancer Gene Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Gene Therapy Consumption Forecast (2022-2028)
9 Global Cancer Gene Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Gene Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ex-vivo Consumption and Growth Rate (2017-2022)
-
9.1.2 Global In-vivo Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Gene Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biopharma Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Gene Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Gene Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ex-vivo Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global In-vivo Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Gene Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Biopharma Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Gene Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Gene Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Gene Therapy Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Cancer Gene Therapy Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Cancer Gene Therapy Product and Service
-
14.3 Adaptimmune
-
14.3.1 Adaptimmune Company Details
-
14.3.2 Adaptimmune Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Adaptimmune Cancer Gene Therapy Product and Service
-
14.4 OncoGenex Pharmaceuticals
-
14.4.1 OncoGenex Pharmaceuticals Company Details
-
14.4.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Service
-
14.5 Bluebird bio, Inc
-
14.5.1 Bluebird bio, Inc Company Details
-
14.5.2 Bluebird bio, Inc Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bluebird bio, Inc Cancer Gene Therapy Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Cancer Gene Therapy Product and Service
-
14.7 SynerGene Therapeutics
-
14.7.1 SynerGene Therapeutics Company Details
-
14.7.2 SynerGene Therapeutics Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 SynerGene Therapeutics Cancer Gene Therapy Product and Service
-
14.8 BioCancell
-
14.8.1 BioCancell Company Details
-
14.8.2 BioCancell Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 BioCancell Cancer Gene Therapy Product and Service
-
14.9 Shenzhen SiBiono GeneTech
-
14.9.1 Shenzhen SiBiono GeneTech Company Details
-
14.9.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Service
-
14.10 Shanghai Sunway Biotech
-
14.10.1 Shanghai Sunway Biotech Company Details
-
14.10.2 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shanghai Sunway Biotech Cancer Gene Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Gene Therapy
-
Figure Cancer Gene Therapy Picture
-
Table Global Cancer Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Gene Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure United States Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ex-vivo Consumption and Growth Rate (2017-2022)
-
Figure Global In-vivo Consumption and Growth Rate (2017-2022)
-
Figure Global Biopharma Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ex-vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In-vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopharma Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Gene Therapy Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Cancer Gene Therapy Product and Service
-
Table Adaptimmune (Foundation Year, Company Profile and etc.)
-
Table Adaptimmune Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adaptimmune Cancer Gene Therapy Product and Service
-
Table OncoGenex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Service
-
Table Bluebird bio, Inc (Foundation Year, Company Profile and etc.)
-
Table Bluebird bio, Inc Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird bio, Inc Cancer Gene Therapy Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Cancer Gene Therapy Product and Service
-
Table SynerGene Therapeutics (Foundation Year, Company Profile and etc.)
-
Table SynerGene Therapeutics Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table SynerGene Therapeutics Cancer Gene Therapy Product and Service
-
Table BioCancell (Foundation Year, Company Profile and etc.)
-
Table BioCancell Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCancell Cancer Gene Therapy Product and Service
-
Table Shenzhen SiBiono GeneTech (Foundation Year, Company Profile and etc.)
-
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Service
-
Table Shanghai Sunway Biotech (Foundation Year, Company Profile and etc.)
-
Table Shanghai Sunway Biotech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Sunway Biotech Cancer Gene Therapy Product and Service
-
